Search Results 231-240 of 5665 for albumin

  1. Patient Stories - Laboratory Medicine and Pathology - Mayo Clinic

    Patient stories · Comprehensive testing leads to targeted treatment for rare autoimmune encephalitis antibody · FISH testing helps detect unseen cancer cells.

  2. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    Albumin ≥ g/dL;; Amylase and lipase ≤.5× ULN (≤× ULN if amylase or lipase is isolated with neither clinical nor radiographic signs of pancreatitis). Last ...

  3. Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery - Mayo Clinic

    Serum bovine immunoglobulin supplementation may improve the quality of life of patients with gynecological cancer. Participation eligibility. Participant ...

  4. A Study to Evaluate EAA181 to Treat Newly-diagnosed Multiple Myeloma - Mayo Clinic

    ... albumin > 3.5 g/dL] AND standard-risk CA AND normal LDH. Stage II: Not R-ISS stage I or III; Stage III: ISS stage III [beta2 macroglobulin > 5.5 mg/L] AND ...

  5. A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

    Serum albumin less than (<) 2.5 grams per deciliter (g/dL); Positive test for human immunodeficiency virus (HIV) and/or active hepatitis B or hepatitis C or ...

  6. Study of SBP-101 in Pancreatic Cancer - Clinical Trials

    Serum albumin <30 g/L (3.0 g/dL); Glycosylated hemoglobin (Hgb A1C) > 8.0%; Life expectancy <16 weeks; Presence of known active bacterial, fungal, or viral ...

  7. Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations - Mayo Clinic

    Serum albumin ≥ 3.5 g/dL. Subjects with tumors potentially highly sensitive to tipifarnib (HRAS mutant VAF ≥35%) may be enrolled despite a serum albumin ...

  8. Respiratory Physiology of Escalating Doses of Nalbuphine Extended-Release Tablets in Patients with IPF - Mayo Clinic

    Liver Function: Total Bilirubin >3mg/dL [>50umol/L] and Serum Albumin <2.8g/dl at screening. Subjects with a history of over sedation or a current clinical ...

  9. Cirrhosis Clinical Trials - Mayo Clinic Research

    ... albumin therapy. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis Scottsdale/Phoenix, AZ. The purpose of this ...

  10. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB